Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and Region (Asia Pacific, Europe, North America, Middle East & Africa, and South America) - Global Forecast to 2028
The pharmaceutical grade lithium carbonate market is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028. Lithium carbonate is commonly used as a mood stabilizer in the treatment of mental conditions such as bipolar disorder. As mental health awareness increases and more people seek treatment, the demand for pharmaceutical grade lithium carbonate is expected to increase.
“By application, extended release segment is expected to be the larger segment during 2023 to 2028.”
The pharmaceutical grade lithium carbonate extended release medications release the drug gradually over an extended period of time. This leads to more consistent drug levels in the bloodstream, reducing the fluctuations that can occur with immediate release medications. This steadier concentration of medicine in the body can lead to better therapeutic outcomes and reduced side effects. Also, many patients suffering from anxiety and other mental illness requires long-term treatment. Extended release formulations are particularly beneficial for these conditions because they provide a sustained effect over time, reducing the need for frequent dosing and improving the patient’s quality of life.
“By region, North America is expected to be the largest market in 2023, by value.”
Mental health awareness has been on the rise in North America, leading to greater recognition and diagnosis of conditions like bipolar disorder. Lithium carbonate is a common treatment for bipolar disorder, and as more individuals seek treatment, the demand for pharmaceutical grade lithium carbonate is expected to increase. North America has a well-developed healthcare infrastructure, which allows for the effective distribution and access to pharmaceuticals. The availability of healthcare services and medications, including pharmaceutical grade lithium carbonate, contributes to market growth.
Profile break-up of primary participants for the report:
Research Coverage:
The report defines, segments, and projects the size of the pharmaceutical grade lithium carbonate contactor market based on application, purity, and region. It strategically profiles the key players and comprehensively analyzes their market share and core competencies. It also tracks and analyzes competitive developments, such as product launch, agreement, acquisition, and investments undertaken by them in the market.
Reasons to Buy the Report:
The report is expected to help the market leaders/new entrants in the market by providing them with the closest approximations of revenue numbers of the pharmaceutical grade lithium carbonate contactor market and its segments. This report is also expected to help stakeholders obtain an improved understanding of the competitive landscape of the market, gain insights to improve the position of their businesses and make suitable go-to-market strategies. It also enables stakeholders to understand the pulse of the market and provide them information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“By application, extended release segment is expected to be the larger segment during 2023 to 2028.”
The pharmaceutical grade lithium carbonate extended release medications release the drug gradually over an extended period of time. This leads to more consistent drug levels in the bloodstream, reducing the fluctuations that can occur with immediate release medications. This steadier concentration of medicine in the body can lead to better therapeutic outcomes and reduced side effects. Also, many patients suffering from anxiety and other mental illness requires long-term treatment. Extended release formulations are particularly beneficial for these conditions because they provide a sustained effect over time, reducing the need for frequent dosing and improving the patient’s quality of life.
“By region, North America is expected to be the largest market in 2023, by value.”
Mental health awareness has been on the rise in North America, leading to greater recognition and diagnosis of conditions like bipolar disorder. Lithium carbonate is a common treatment for bipolar disorder, and as more individuals seek treatment, the demand for pharmaceutical grade lithium carbonate is expected to increase. North America has a well-developed healthcare infrastructure, which allows for the effective distribution and access to pharmaceuticals. The availability of healthcare services and medications, including pharmaceutical grade lithium carbonate, contributes to market growth.
Profile break-up of primary participants for the report:
- By Company Type: Tier 1 - 65%, Tier 2 - 20%, and Tier 3 - 15%
- By Designation: C-level Executives - 25%, Directors - 30%, and Others - 45%
- By Region: North America - 20%, Europe - 15%, Asia Pacific - 55%, Middle East & Africa - 3%, South America - 7%
Research Coverage:
The report defines, segments, and projects the size of the pharmaceutical grade lithium carbonate contactor market based on application, purity, and region. It strategically profiles the key players and comprehensively analyzes their market share and core competencies. It also tracks and analyzes competitive developments, such as product launch, agreement, acquisition, and investments undertaken by them in the market.
Reasons to Buy the Report:
The report is expected to help the market leaders/new entrants in the market by providing them with the closest approximations of revenue numbers of the pharmaceutical grade lithium carbonate contactor market and its segments. This report is also expected to help stakeholders obtain an improved understanding of the competitive landscape of the market, gain insights to improve the position of their businesses and make suitable go-to-market strategies. It also enables stakeholders to understand the pulse of the market and provide them information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (rising cases of mental illness), restraints (side effects and safety concerns), opportunities (potential for new applications owing to clinical research and innovation), and challenges (stigma and perception of mental health disorder) influencing the growth of the pharmaceutical grade lithium carbonate contactor market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the pharmaceutical grade lithium carbonate contactor market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical grade lithium carbonate contactor market across varied regions.
- Market Diversification: Exhaustive information about new products, various production technologies, untapped geographies, recent developments, and investments in the pharmaceutical grade lithium carbonate contactor market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Livent Corporation (US), Albemarle Corporation (US), Jiangsu Lianhuan Pharmaceutical Co., Ltd. (China), American Elements (US), Globe Quнmica (US), Jiangsu Nhwa Pharmaceutical Co., Ltd. (China), Panchsheel Organics Ltd (POLTD) (India), Blanver (Brazil), among others in the pharmaceutical grade lithium carbonate contactor market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
TABLE 1 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNITS CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Companies participating in primary research
2.1.2.3 Breakdown of primary interviews
2.2 DEMAND-SIDE APPROACH
FIGURE 3 MAIN MATRIX CONSIDERED TO CONSTRUCT AND ASSESS DEMAND FOR PHARMACEUTICAL GRADE LITHIUM CARBONATE
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.4 SUPPLY-SIDE APPROACH
FIGURE 6 METHODOLOGY FOR SUPPLY-SIDE SIZING OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET (1/2)
FIGURE 7 METHODOLOGY FOR SUPPLY-SIDE SIZING OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET (2/2)
2.4.1 CALCULATIONS FOR SUPPLY-SIDE ANALYSIS
2.5 DATA TRIANGULATION
FIGURE 8 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: DATA TRIANGULATION
2.6 GROWTH FORECAST
2.7 GROWTH RATE ASSUMPTIONS
2.8 RESEARCH ASSUMPTIONS
2.9 RESEARCH LIMITATIONS
2.10 RISK ANALYSIS
2.11 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
TABLE 2 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SNAPSHOT: 2023 VS. 2028
FIGURE 9 EXTENDED-RELEASE SEGMENT TO HOLD LARGER MARKET SHARE DURING FORECAST PERIOD
FIGURE 10 NORTH AMERICA TO LEAD THE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET DURING FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
FIGURE 11 RISE IN CASES OF MENTAL ILLNESS TO DRIVE MARKET
4.2 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION
FIGURE 12 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION
FIGURE 13 EXTENDED-RELEASE SEGMENT TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
4.4 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
FIGURE 14 EXTENDED-RELEASE APPLICATION ACCOUNTS FOR LARGER MARKET SHARE
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
5.2.1 DRIVERS
5.2.1.1 Rising cases of mental illness
FIGURE 16 PREVALENCE OF MENTAL DISORDERS ACROSS WHO REGIONS, 2019
5.2.1.1.1 Growing awareness of mental health
5.2.1.1.2 Changes in lifestyle and increase in stress
5.2.2 RESTRAINTS
5.2.2.1 Availability of substitutes
5.2.2.2 Side effects and safety concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Potential for new applications owing to clinical research and innovation
5.2.4 CHALLENGES
5.2.4.1 Stringent pharmaceutical standards and regulations
5.2.4.2 Stigma and perception of mental disorders
6 INDUSTRY TRENDS
6.1 ECOSYSTEM MAPPING
FIGURE 17 ECOSYSTEM MAP OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
TABLE 3 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: ECOSYSTEM MAPPING
6.2 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
6.2.1 LITHIUM RESOURCE EXTRACTION AND PROCESSING
6.2.2 CONVERSION TO LITHIUM CARBONATE
6.2.3 PURIFICATION AND QUALITY CONTROL
6.2.4 PHARMACEUTICAL FORMULATION AND MANUFACTURING OF PHARMACEUTICAL PRODUCTS
6.2.5 REGULATORY COMPLIANCE AND TESTING
6.2.6 DISTRIBUTION AND SUPPLY CHAIN
6.2.7 PHARMACEUTICAL USE
6.3 TECHNOLOGY ANALYSIS
6.4 REGULATORY LANDSCAPE
6.4.1 REGULATIONS RELATED TO PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
6.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.5 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 8 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: CONFERENCES AND EVENTS, 2023–2024
6.6 PATENT ANALYSIS
6.6.1 INTRODUCTION
6.6.2 METHODOLOGY
6.6.3 DOCUMENT TYPE
FIGURE 19 NUMBER OF GRANTED PATENTS, PATENT APPLICATIONS, AND LIMITED PATENTS
FIGURE 20 PUBLICATION TRENDS IN LAST 10 YEARS
6.6.4 INSIGHTS
FIGURE 21 LEGAL STATUS OF PATENTS
6.6.5 JURISDICTION ANALYSIS
FIGURE 22 TOP JURISDICTION, BY DOCUMENT
6.6.6 TOP COMPANIES/APPLICANTS
FIGURE 23 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS
TABLE 9 PATENTS: OROCOBRE LIMITED
TABLE 10 PATENTS: CONTITECH USA INC.
TABLE 11 TOP PATENT OWNERS DURING LAST 10 YEARS
6.7 KEY STAKEHOLDERS AND BUYING CRITERIA
6.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO APPLICATIONS
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO APPLICATIONS (%)
6.7.2 BUYING CRITERIA
FIGURE 25 KEY BUYING CRITERIA FOR TOP TWO APPLICATIONS
TABLE 13 KEY BUYING CRITERIA FOR TOP TWO APPLICATIONS
6.8 CASE STUDY ANALYSIS
6.8.1 OBJECTIVE
6.8.2 DESCRIPTION
6.8.3 METHOD
6.8.4 RESULTS
6.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 26 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
TABLE 14 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: PORTER’S FIVE FORCES ANALYSIS
6.9.1 THREAT OF NEW ENTRANTS
6.9.2 THREAT OF SUBSTITUTES
6.9.3 BARGAINING POWER OF BUYERS
6.9.4 BARGAINING POWER OF SUPPLIERS
6.9.5 INTENSITY OF COMPETITIVE RIVALRY
6.10 TRADE ANALYSIS
6.10.1 IMPORT-EXPORT SCENARIO
TABLE 15 LITHIUM CARBONATE EXPORT TRADE DATA, 2022
TABLE 16 LITHIUM CARBONATE IMPORT TRADE DATA, 2022
6.11 PRICING ANALYSIS
6.11.1 AVERAGE SELLING PRICE FOR PHARMACEUTICAL GRADE LITHIUM CARBONATE, BY REGION IN 2022
FIGURE 27 AVERAGE SELLING PRICE, BY REGION
7 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY PURITY
7.1 INTRODUCTION
7.2 99.0%
7.3 ABOVE 99%
8 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION
8.1 INTRODUCTION
FIGURE 28 EXTENDED RELEASE TO BE LARGER MARKET SEGMENT DURING FORECAST PERIOD
TABLE 17 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 18 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
TABLE 19 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 20 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
8.2 IMMEDIATE RELEASE
8.2.1 IMMEDIATE-RELEASE MEDICINES PROVIDE RAPID RELIEF OF SYMPTOMS
TABLE 21 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (TON)
TABLE 22 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (TON)
TABLE 23 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 24 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (USD MILLION)
8.3 EXTENDED RELEASE
8.3.1 EXTENDED-RELEASE MEDICINES REDUCE RISK OF SIDE EFFECTS
TABLE 25 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (TON)
TABLE 26 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (TON)
TABLE 27 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 28 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (USD MILLION)
9 PHARMACEUTICAL GRADE LITHIUM CARBONATE, BY REGION
9.1 INTRODUCTION
FIGURE 29 NORTH AMERICA TO DRIVE PHARMACEUTICAL GRADE LITHIUM CARBONATE DURING FORECAST PERIOD
TABLE 29 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 30 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 31 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (TON)
TABLE 32 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (TON)
9.2 ASIA PACIFIC
9.2.1 RECESSION IMPACT
FIGURE 30 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE SNAPSHOT
TABLE 33 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 34 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 36 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 37 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 38 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 39 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 40 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.2 CHINA
9.2.2.1 Expansion of treatment facilities pertaining to mental disorders to drive market
TABLE 41 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 42 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 43 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 44 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.3 INDIA
9.2.3.1 Government initiatives for encouraging mental health treatments to drive demand
TABLE 45 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 46 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 47 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 48 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.4 JAPAN
9.2.4.1 Increasing need for treatment of mental illnesses to drive market
TABLE 49 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 50 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 51 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 52 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.5 SOUTH KOREA
9.2.5.1 Presence of mental health centers to improve research and increase demand
TABLE 53 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 54 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 55 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 56 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.6 REST OF ASIA PACIFIC
TABLE 57 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 58 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 59 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 60 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3 NORTH AMERICA
9.3.1 RECESSION IMPACT
FIGURE 31 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE SNAPSHOT
TABLE 61 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 62 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 64 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 65 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 66 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 68 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3.2 US
9.3.2.1 Laws pertaining to mental health and disorder treatment to drive demand
TABLE 69 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 70 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 71 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 72 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3.3 CANADA
9.3.3.1 Investment in quality mental health treatment to drive growth
TABLE 73 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 74 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 75 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 76 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3.4 MEXICO
9.3.4.1 Campaigns and educational initiatives to influence growth
TABLE 77 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 78 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 79 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 80 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4 EUROPE
9.4.1 RECESSION IMPACT
FIGURE 32 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SNAPSHOT
TABLE 81 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 82 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 83 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 84 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 85 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 86 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 87 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 88 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.2 GERMANY
9.4.2.1 Well-established healthcare system to drive market
TABLE 89 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 90 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 91 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 92 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.3 FRANCE
9.4.3.1 Support and initiative from government toward mental health issues to drive demand
TABLE 93 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 94 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 95 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 96 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.4 UK
9.4.4.1 Growing cases of mental illness to drive demand
TABLE 97 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 98 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 99 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 100 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.5 REST OF EUROPE
TABLE 101 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 102 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 103 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 104 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5 MIDDLE EAST & AFRICA
9.5.1 RECESSION IMPACT
TABLE 105 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 106 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 108 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 109 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 112 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5.2 SAUDI ARABIA
9.5.2.1 Growing awareness and government support for mental illness to drive demand
TABLE 113 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 114 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 115 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 116 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5.3 UAE
9.5.3.1 Growing investment to improve drug sector to drive demand
TABLE 117 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 118 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 119 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 120 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5.3.2 Rest of Middle East & Africa
TABLE 121 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 122 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 123 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 124 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.6 SOUTH AMERICA
9.6.1 RECESSION IMPACT
TABLE 125 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 126 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 127 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 128 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 129 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 130 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 131 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 132 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.6.2 BRAZIL
9.6.2.1 Growing efforts to raise awareness about mental health issues to drive market
TABLE 133 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 134 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 135 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 136 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.6.3 REST OF SOUTH AMERICA
TABLE 137 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 138 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 139 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 140 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 141 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
10.3 MARKET SHARE ANALYSIS
10.3.1 RANKING OF KEY MARKET PLAYERS, 2022
FIGURE 33 RANKING OF KEY PLAYERS IN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, 2022
10.3.2 MARKET SHARE OF KEY PLAYERS
FIGURE 34 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE ANALYSIS
TABLE 142 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: DEGREE OF COMPETITION
10.3.2.1 Livent Corporation
10.3.2.2 Albemarle Corporation
10.3.2.3 Jiangsu Lianhuan Pharmaceutical Co., Ltd.
10.3.3 REVENUE ANALYSIS OF TOP PLAYERS
FIGURE 35 REVENUE ANALYSIS OF KEY COMPANIES, 2018–2022
10.4 COMPANY PRODUCT FOOTPRINT ANALYSIS
FIGURE 36 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: COMPANY FOOTPRINT
TABLE 143 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: PURITY FOOTPRINT
TABLE 144 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: COMPANY REGION FOOTPRINT
10.5 COMPANY EVALUATION MATRIX (TIER 1)
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 37 COMPANY EVALUATION MATRIX: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET (TIER 1 COMPANIES)
10.6 COMPETITIVE BENCHMARKING
TABLE 145 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: KEY STARTUPS/SMES
TABLE 146 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7 STARTUP/SME EVALUATION MATRIX
10.7.1 PROGRESSIVE COMPANIES
10.7.2 RESPONSIVE COMPANIES
10.7.3 DYNAMIC COMPANIES
10.7.4 STARTING BLOCKS
FIGURE 38 STARTUP/SME EVALUATION QUADRANT: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
10.8 COMPETITIVE SCENARIO
10.8.1 DEALS
TABLE 147 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: DEALS, 2019–2023
10.8.2 OTHER DEVELOPMENTS
TABLE 148 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: EXPANSIONS AND INVESTMENTS, 2019–2023
11 COMPANY PROFILES
(Business overview, Products/Solutions/Services offered, Recent Developments, MNM view)*
11.1 MAJOR PLAYERS
11.1.1 LIVENT CORPORATION
TABLE 149 LIVENT CORPORATION: COMPANY OVERVIEW
FIGURE 39 LIVENT CORPORATION: COMPANY SNAPSHOT
TABLE 150 LIVENT CORPORATION: PRODUCTS OFFERED
TABLE 151 LIVENT CORPORATION: DEALS
11.1.2 ALBEMARLE CORPORATION
TABLE 152 ALBEMARLE CORPORATION: COMPANY OVERVIEW
FIGURE 40 ALBEMARLE CORPORATION: COMPANY SNAPSHOT
TABLE 153 ALBEMARLE CORPORATION: PRODUCTS OFFERED
TABLE 154 ALBEMARLE CORPORATION: OTHERS
11.1.3 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.
TABLE 155 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
FIGURE 41 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 156 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
11.1.4 AMERICAN ELEMENTS
TABLE 157 AMERICAN ELEMENTS: COMPANY OVERVIEW
TABLE 158 AMERICAN ELEMENTS: PRODUCTS OFFERED
11.1.5 GLOBE QUНMICA
TABLE 159 GLOBE QUНMICA: COMPANY OVERVIEW
TABLE 160 GLOBE QUНMICA: PRODUCTS OFFERED
11.1.6 JIANGSU NHWA PHARMACEUTICAL CO., LTD.
TABLE 161 JIANGSU NHWA PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
TABLE 162 JIANGSU NHWA PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
11.1.7 PANCHSHEEL ORGANICS LTD (POLTD)
TABLE 163 PANCHSHEEL ORGANICS LTD (POLTD): COMPANY OVERVIEW
FIGURE 42 PANCHSHEEL ORGANICS LTD (POLTD): COMPANY SNAPSHOT
TABLE 164 PANCHSHEEL ORGANICS LTD (POLTD): PRODUCTS OFFERED
11.1.8 BLANVER
TABLE 165 BLANVER: COMPANY OVERVIEW
TABLE 166 BLANVER: PRODUCTS OFFERED
11.2 OTHER PLAYERS
11.2.1 ZHENJIANG POWORKS CO., LTD.
TABLE 167 ZHENJIANG POWORKS CO., LTD.: COMPANY OVERVIEW
11.2.2 AXIOM CHEMICALS PVT. LTD.
TABLE 168 AXIOM CHEMICALS PVT. LTD.: COMPANY OVERVIEW
11.2.3 HUBEI RISON CHEMICAL CO., LTD.
TABLE 169 HUBEI RISON CHEMICAL CO., LTD.: COMPANY OVERVIEW
11.2.4 PHARMAFFILIATES ANALYTICS AND SYNTHETICS P. LTD.
TABLE 170 PHARMAFFILIATES ANALYTICS AND SYNTHETICS P. LTD.: COMPANY OVERVIEW
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
TABLE 1 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNITS CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Companies participating in primary research
2.1.2.3 Breakdown of primary interviews
2.2 DEMAND-SIDE APPROACH
FIGURE 3 MAIN MATRIX CONSIDERED TO CONSTRUCT AND ASSESS DEMAND FOR PHARMACEUTICAL GRADE LITHIUM CARBONATE
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.4 SUPPLY-SIDE APPROACH
FIGURE 6 METHODOLOGY FOR SUPPLY-SIDE SIZING OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET (1/2)
FIGURE 7 METHODOLOGY FOR SUPPLY-SIDE SIZING OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET (2/2)
2.4.1 CALCULATIONS FOR SUPPLY-SIDE ANALYSIS
2.5 DATA TRIANGULATION
FIGURE 8 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: DATA TRIANGULATION
2.6 GROWTH FORECAST
2.7 GROWTH RATE ASSUMPTIONS
2.8 RESEARCH ASSUMPTIONS
2.9 RESEARCH LIMITATIONS
2.10 RISK ANALYSIS
2.11 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
TABLE 2 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SNAPSHOT: 2023 VS. 2028
FIGURE 9 EXTENDED-RELEASE SEGMENT TO HOLD LARGER MARKET SHARE DURING FORECAST PERIOD
FIGURE 10 NORTH AMERICA TO LEAD THE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET DURING FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
FIGURE 11 RISE IN CASES OF MENTAL ILLNESS TO DRIVE MARKET
4.2 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION
FIGURE 12 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION
FIGURE 13 EXTENDED-RELEASE SEGMENT TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
4.4 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
FIGURE 14 EXTENDED-RELEASE APPLICATION ACCOUNTS FOR LARGER MARKET SHARE
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
5.2.1 DRIVERS
5.2.1.1 Rising cases of mental illness
FIGURE 16 PREVALENCE OF MENTAL DISORDERS ACROSS WHO REGIONS, 2019
5.2.1.1.1 Growing awareness of mental health
5.2.1.1.2 Changes in lifestyle and increase in stress
5.2.2 RESTRAINTS
5.2.2.1 Availability of substitutes
5.2.2.2 Side effects and safety concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Potential for new applications owing to clinical research and innovation
5.2.4 CHALLENGES
5.2.4.1 Stringent pharmaceutical standards and regulations
5.2.4.2 Stigma and perception of mental disorders
6 INDUSTRY TRENDS
6.1 ECOSYSTEM MAPPING
FIGURE 17 ECOSYSTEM MAP OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
TABLE 3 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: ECOSYSTEM MAPPING
6.2 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
6.2.1 LITHIUM RESOURCE EXTRACTION AND PROCESSING
6.2.2 CONVERSION TO LITHIUM CARBONATE
6.2.3 PURIFICATION AND QUALITY CONTROL
6.2.4 PHARMACEUTICAL FORMULATION AND MANUFACTURING OF PHARMACEUTICAL PRODUCTS
6.2.5 REGULATORY COMPLIANCE AND TESTING
6.2.6 DISTRIBUTION AND SUPPLY CHAIN
6.2.7 PHARMACEUTICAL USE
6.3 TECHNOLOGY ANALYSIS
6.4 REGULATORY LANDSCAPE
6.4.1 REGULATIONS RELATED TO PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
6.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.5 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 8 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: CONFERENCES AND EVENTS, 2023–2024
6.6 PATENT ANALYSIS
6.6.1 INTRODUCTION
6.6.2 METHODOLOGY
6.6.3 DOCUMENT TYPE
FIGURE 19 NUMBER OF GRANTED PATENTS, PATENT APPLICATIONS, AND LIMITED PATENTS
FIGURE 20 PUBLICATION TRENDS IN LAST 10 YEARS
6.6.4 INSIGHTS
FIGURE 21 LEGAL STATUS OF PATENTS
6.6.5 JURISDICTION ANALYSIS
FIGURE 22 TOP JURISDICTION, BY DOCUMENT
6.6.6 TOP COMPANIES/APPLICANTS
FIGURE 23 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS
TABLE 9 PATENTS: OROCOBRE LIMITED
TABLE 10 PATENTS: CONTITECH USA INC.
TABLE 11 TOP PATENT OWNERS DURING LAST 10 YEARS
6.7 KEY STAKEHOLDERS AND BUYING CRITERIA
6.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO APPLICATIONS
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO APPLICATIONS (%)
6.7.2 BUYING CRITERIA
FIGURE 25 KEY BUYING CRITERIA FOR TOP TWO APPLICATIONS
TABLE 13 KEY BUYING CRITERIA FOR TOP TWO APPLICATIONS
6.8 CASE STUDY ANALYSIS
6.8.1 OBJECTIVE
6.8.2 DESCRIPTION
6.8.3 METHOD
6.8.4 RESULTS
6.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 26 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
TABLE 14 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: PORTER’S FIVE FORCES ANALYSIS
6.9.1 THREAT OF NEW ENTRANTS
6.9.2 THREAT OF SUBSTITUTES
6.9.3 BARGAINING POWER OF BUYERS
6.9.4 BARGAINING POWER OF SUPPLIERS
6.9.5 INTENSITY OF COMPETITIVE RIVALRY
6.10 TRADE ANALYSIS
6.10.1 IMPORT-EXPORT SCENARIO
TABLE 15 LITHIUM CARBONATE EXPORT TRADE DATA, 2022
TABLE 16 LITHIUM CARBONATE IMPORT TRADE DATA, 2022
6.11 PRICING ANALYSIS
6.11.1 AVERAGE SELLING PRICE FOR PHARMACEUTICAL GRADE LITHIUM CARBONATE, BY REGION IN 2022
FIGURE 27 AVERAGE SELLING PRICE, BY REGION
7 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY PURITY
7.1 INTRODUCTION
7.2 99.0%
7.3 ABOVE 99%
8 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION
8.1 INTRODUCTION
FIGURE 28 EXTENDED RELEASE TO BE LARGER MARKET SEGMENT DURING FORECAST PERIOD
TABLE 17 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 18 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
TABLE 19 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 20 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
8.2 IMMEDIATE RELEASE
8.2.1 IMMEDIATE-RELEASE MEDICINES PROVIDE RAPID RELIEF OF SYMPTOMS
TABLE 21 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (TON)
TABLE 22 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (TON)
TABLE 23 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 24 IMMEDIATE RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (USD MILLION)
8.3 EXTENDED RELEASE
8.3.1 EXTENDED-RELEASE MEDICINES REDUCE RISK OF SIDE EFFECTS
TABLE 25 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (TON)
TABLE 26 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (TON)
TABLE 27 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 28 EXTENDED RELEASE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (USD MILLION)
9 PHARMACEUTICAL GRADE LITHIUM CARBONATE, BY REGION
9.1 INTRODUCTION
FIGURE 29 NORTH AMERICA TO DRIVE PHARMACEUTICAL GRADE LITHIUM CARBONATE DURING FORECAST PERIOD
TABLE 29 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 30 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (USD MILLION)
TABLE 31 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2019–2022 (TON)
TABLE 32 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY REGION, 2023–2028 (TON)
9.2 ASIA PACIFIC
9.2.1 RECESSION IMPACT
FIGURE 30 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE SNAPSHOT
TABLE 33 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 34 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 36 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 37 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 38 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 39 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 40 ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.2 CHINA
9.2.2.1 Expansion of treatment facilities pertaining to mental disorders to drive market
TABLE 41 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 42 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 43 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 44 CHINA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.3 INDIA
9.2.3.1 Government initiatives for encouraging mental health treatments to drive demand
TABLE 45 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 46 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 47 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 48 INDIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.4 JAPAN
9.2.4.1 Increasing need for treatment of mental illnesses to drive market
TABLE 49 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 50 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 51 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 52 JAPAN: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.5 SOUTH KOREA
9.2.5.1 Presence of mental health centers to improve research and increase demand
TABLE 53 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 54 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 55 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 56 SOUTH KOREA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.2.6 REST OF ASIA PACIFIC
TABLE 57 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 58 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 59 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 60 REST OF ASIA PACIFIC: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3 NORTH AMERICA
9.3.1 RECESSION IMPACT
FIGURE 31 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE SNAPSHOT
TABLE 61 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 62 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 64 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 65 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 66 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 68 NORTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3.2 US
9.3.2.1 Laws pertaining to mental health and disorder treatment to drive demand
TABLE 69 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 70 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 71 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 72 US: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3.3 CANADA
9.3.3.1 Investment in quality mental health treatment to drive growth
TABLE 73 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 74 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 75 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 76 CANADA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.3.4 MEXICO
9.3.4.1 Campaigns and educational initiatives to influence growth
TABLE 77 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 78 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 79 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 80 MEXICO: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4 EUROPE
9.4.1 RECESSION IMPACT
FIGURE 32 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SNAPSHOT
TABLE 81 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 82 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 83 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 84 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 85 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 86 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 87 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 88 EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.2 GERMANY
9.4.2.1 Well-established healthcare system to drive market
TABLE 89 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 90 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 91 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 92 GERMANY: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.3 FRANCE
9.4.3.1 Support and initiative from government toward mental health issues to drive demand
TABLE 93 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 94 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 95 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 96 FRANCE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.4 UK
9.4.4.1 Growing cases of mental illness to drive demand
TABLE 97 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 98 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 99 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 100 UK: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.4.5 REST OF EUROPE
TABLE 101 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 102 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 103 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 104 REST OF EUROPE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5 MIDDLE EAST & AFRICA
9.5.1 RECESSION IMPACT
TABLE 105 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 106 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 108 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 109 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 112 MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5.2 SAUDI ARABIA
9.5.2.1 Growing awareness and government support for mental illness to drive demand
TABLE 113 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 114 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 115 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 116 SAUDI ARABIA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5.3 UAE
9.5.3.1 Growing investment to improve drug sector to drive demand
TABLE 117 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 118 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 119 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 120 UAE: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.5.3.2 Rest of Middle East & Africa
TABLE 121 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 122 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 123 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 124 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.6 SOUTH AMERICA
9.6.1 RECESSION IMPACT
TABLE 125 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
TABLE 126 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
TABLE 127 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2019–2022 (TON)
TABLE 128 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY COUNTRY, 2023–2028 (TON)
TABLE 129 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 130 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 131 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 132 SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.6.2 BRAZIL
9.6.2.1 Growing efforts to raise awareness about mental health issues to drive market
TABLE 133 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 134 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 135 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 136 BRAZIL: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
9.6.3 REST OF SOUTH AMERICA
TABLE 137 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (USD MILLION)
TABLE 138 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (USD MILLION)
TABLE 139 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2019–2022 (TON)
TABLE 140 REST OF SOUTH AMERICA: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, BY APPLICATION, 2023–2028 (TON)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 141 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
10.3 MARKET SHARE ANALYSIS
10.3.1 RANKING OF KEY MARKET PLAYERS, 2022
FIGURE 33 RANKING OF KEY PLAYERS IN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET, 2022
10.3.2 MARKET SHARE OF KEY PLAYERS
FIGURE 34 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE ANALYSIS
TABLE 142 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: DEGREE OF COMPETITION
10.3.2.1 Livent Corporation
10.3.2.2 Albemarle Corporation
10.3.2.3 Jiangsu Lianhuan Pharmaceutical Co., Ltd.
10.3.3 REVENUE ANALYSIS OF TOP PLAYERS
FIGURE 35 REVENUE ANALYSIS OF KEY COMPANIES, 2018–2022
10.4 COMPANY PRODUCT FOOTPRINT ANALYSIS
FIGURE 36 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: COMPANY FOOTPRINT
TABLE 143 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: PURITY FOOTPRINT
TABLE 144 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: COMPANY REGION FOOTPRINT
10.5 COMPANY EVALUATION MATRIX (TIER 1)
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 37 COMPANY EVALUATION MATRIX: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET (TIER 1 COMPANIES)
10.6 COMPETITIVE BENCHMARKING
TABLE 145 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: KEY STARTUPS/SMES
TABLE 146 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7 STARTUP/SME EVALUATION MATRIX
10.7.1 PROGRESSIVE COMPANIES
10.7.2 RESPONSIVE COMPANIES
10.7.3 DYNAMIC COMPANIES
10.7.4 STARTING BLOCKS
FIGURE 38 STARTUP/SME EVALUATION QUADRANT: PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET
10.8 COMPETITIVE SCENARIO
10.8.1 DEALS
TABLE 147 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: DEALS, 2019–2023
10.8.2 OTHER DEVELOPMENTS
TABLE 148 PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET: EXPANSIONS AND INVESTMENTS, 2019–2023
11 COMPANY PROFILES
(Business overview, Products/Solutions/Services offered, Recent Developments, MNM view)*
11.1 MAJOR PLAYERS
11.1.1 LIVENT CORPORATION
TABLE 149 LIVENT CORPORATION: COMPANY OVERVIEW
FIGURE 39 LIVENT CORPORATION: COMPANY SNAPSHOT
TABLE 150 LIVENT CORPORATION: PRODUCTS OFFERED
TABLE 151 LIVENT CORPORATION: DEALS
11.1.2 ALBEMARLE CORPORATION
TABLE 152 ALBEMARLE CORPORATION: COMPANY OVERVIEW
FIGURE 40 ALBEMARLE CORPORATION: COMPANY SNAPSHOT
TABLE 153 ALBEMARLE CORPORATION: PRODUCTS OFFERED
TABLE 154 ALBEMARLE CORPORATION: OTHERS
11.1.3 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.
TABLE 155 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
FIGURE 41 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 156 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
11.1.4 AMERICAN ELEMENTS
TABLE 157 AMERICAN ELEMENTS: COMPANY OVERVIEW
TABLE 158 AMERICAN ELEMENTS: PRODUCTS OFFERED
11.1.5 GLOBE QUНMICA
TABLE 159 GLOBE QUНMICA: COMPANY OVERVIEW
TABLE 160 GLOBE QUНMICA: PRODUCTS OFFERED
11.1.6 JIANGSU NHWA PHARMACEUTICAL CO., LTD.
TABLE 161 JIANGSU NHWA PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
TABLE 162 JIANGSU NHWA PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
11.1.7 PANCHSHEEL ORGANICS LTD (POLTD)
TABLE 163 PANCHSHEEL ORGANICS LTD (POLTD): COMPANY OVERVIEW
FIGURE 42 PANCHSHEEL ORGANICS LTD (POLTD): COMPANY SNAPSHOT
TABLE 164 PANCHSHEEL ORGANICS LTD (POLTD): PRODUCTS OFFERED
11.1.8 BLANVER
TABLE 165 BLANVER: COMPANY OVERVIEW
TABLE 166 BLANVER: PRODUCTS OFFERED
11.2 OTHER PLAYERS
11.2.1 ZHENJIANG POWORKS CO., LTD.
TABLE 167 ZHENJIANG POWORKS CO., LTD.: COMPANY OVERVIEW
11.2.2 AXIOM CHEMICALS PVT. LTD.
TABLE 168 AXIOM CHEMICALS PVT. LTD.: COMPANY OVERVIEW
11.2.3 HUBEI RISON CHEMICAL CO., LTD.
TABLE 169 HUBEI RISON CHEMICAL CO., LTD.: COMPANY OVERVIEW
11.2.4 PHARMAFFILIATES ANALYTICS AND SYNTHETICS P. LTD.
TABLE 170 PHARMAFFILIATES ANALYTICS AND SYNTHETICS P. LTD.: COMPANY OVERVIEW
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
